Several organophosphate and organochlorine compounds, including pesticides commonly found in the Great Lakes basin, have the potential to induce immunotoxicity. Because of biomagnification and accumulation in the food chain, Great Lakes residents may inadvertently be exposed to these compounds and thus face increased risk of immune dysfunction. In spite of the laboratory animal data and evidence from occupational exposures that suggest immunotoxicity, there is no definitive evidence as yet that environmental exposure to these xenobiotics poses a significant threat to the human immune system that is sufficient to predispose residents of the Great Lakes basin to increased disease. However, uncertainties with regard to exposure levels, predictability of tests, suitability of the animal models, and immune reserve cannot be ruled out when making risk assessment decisions such as this. -Environ Health Perspect 1 03(Suppl 9): 55-61 (1995) 
Introduction
Pesticides are among the many chemicals present in the Great Lakes basin. Four of these pesticides, including hexachlorobenzene (HCB), mirex, dieldrin, and dichlorodiphenyltrichloroethane (DDT) and its metabolites, have the potential to produce immunotoxicity and are thus among the 11 chlordane and malathion have the potential for human exposure through the food chain (2) . In addition to the presence of measurable residues in fish and wildlife as well as people living in the Great Lakes basin, the pesticides listed above have documented immunotoxic effects in laboratory animal studies. The effects range from an increased incidence of experimental infection to specific effects on immune system structure (histopathology) and function (3) (4) (5) .
Due to the persistent nature of these compounds and biomagnification and accumulation in the food chain, Great Lakes residents who consume large amounts of contaminated fish and wildlife may ingest greater amounts of these compounds than the general population. At the present time there is no clear evidence that environmental exposure to these pesticides through consumption of contaminated fish or wildlife in the Great Lakes Basin poses a threat to the human immune system. Currently, the best source of information concerning the potential immunotoxic effects of these pesticides in humans comes from laboratory animal studies. These studies have shown that under defined conditions these compounds can modulate the immune system. Generally, the effects are seen only in carefully controlled laboratory studies using inbred or hybrid strains of experimental animals. Furthermore, the doses of pesticide required to modulate the immune response are often orders of magnitude higher than those reported for human exposure.
A review of pertinent laboratory animal studies, as well as epidemiology reports of occupational exposure to pesticides, and potential immunotoxicity is presented. There are data that suggest that occupational exposure to pesticides, especially in situations where high concentrations of material are present, can induce contact and immediate (respiratory) sensitization. [For recent reviews on this subject, see Edmiston and Maddy (3), Thomas et al. (5) , and Murray and Thomas (6) ]. Emphasis in this review is placed on data concerning the potential immunosuppressive effects of pesticides and related compounds that tend to persist in the environment and may be particularly important under chronic exposure conditions such as those encountered in and around the Great Lakes Basin.
Animal Studies
Several organophosphate and organochlorine compounds, including pesticides commonly found in the Great Lakes basin, have been shown to alter immune function in laboratory animals. Typically, laboratory animal studies are conducted under carefully controlled conditions with acute or relatively short-term exposures at concentrations considerably higher than those encountered in the environment. Considerable variation exists in animal species used and in route, duration, and level of exposure, as well as end point examined. In almost no case were efforts made to verify actual delivered dose. In studies involving dose-response experiments, little effort is ever made to determine a lowest observable effect level (LOEL). In some cases, increased susceptibility to an infectious agent and alterations in immune-function parameters were reported; in others, only changes in immune function were examined. (15) (16) (17) .
Extensive studies by Rodgers and colleagues (18) (19) (20) (21) (22) (23) (18) (19) (20) (21) (22) (23) . The dose levels with which effects were seen ranged from 0.5 to 10 mg/kg. Rats treated orally with a single dose of 20 mg/kg OOS-TMP exhibited altered macrophage cytotoxicity and esterase activity, which may contribute to the pathogenesis of lung injury seen in rats treated with these compounds (24) .
Hinton et al. (25) illustrated that toxicity observed in health effect studies of these compounds is often due to technical-grade contaminants. No statistically significant suppression of immune status (antibody titers, serum immunoglobulins, immunohistopathology) was noted in SpragueDawley rats receiving pure triphenyl phosphate (TPP) at doses up to 10,000 ppm in the diet for 120 days. Although the data suggest that TPP has no effect on innate or adoptive immunity, the extremely small numbers of animals/dose/end point (i.e., two to three rats per point for antibody titers) limit the statistical power of this study.
Hexachiorobenzene
Hexachlorobenzene (HCB) is one of the most persistent and ubiquitous chemicals in the environment. It is no longer manufactured in Canada or the United States for use as a fungicide, although it is generated in significant quantities as a by-product (26) . The acute toxicity of HCB is relatively low in laboratory animals, and the oral LD50 (lethal dose, 50%) for rats is greater than 3000 mg/kg (27) .
Animal studies have demonstrated species-specific effects of HCB on the immune system. Based upon studies by Loose et al. (28) , increased susceptibility to infection and increased sensitivity to endotoxin challenge were noted in mice fed approximately 30 mg HCB/kg/day. Unfortunately, a no observable adverse effect level (NOAEL) could not be estimated from these studies since single concentrations of HCB were administered. Effects on the generation of humoral immunity are less clear cut (29) . Barnett et al. (30) reported that in the absence of changes in splenic B-and Tcell mitogenesis, antigen-specific delayedtype hypersensitivity and mixed lymphocyte culture responses were suppressed in mice exposed perinatally to up to 5 mg/kg HCB. On the other hand, combined prenatal and postnatal exposure of rats to as little as 4 mg/kg HCB significantly increased immunoglobulins M and G (IgM, IgG) antibody titers to tetanus toxoid as well as delayed hypersensitivity to ovalbumin in a dose-dependent manner relative to controls (31 (33) . Lymphoproliferative responses to T-and B-cell mitogens in these studies in the lung-associated and mesenteric lymph nodes exhibited differential. effects depending upon location and duration of exposure. In other studies, evidence of reduced pulmonary natural killer cell activity was observed in rats following oral exposure to 150 mg/kg HCB in the diet for 6 weeks (34); unfortunately, a NOAEL could not be determined from this study. Proliferation of lymph node, high endothelial venules following HCB exposure noted by Kitchin et al. (35) , as well as Vos et al. (36) , in rats at prenatal and postnatal HCB doses of 50 mg/kg/day may alter Tand B-lymphocyte trafficking and explain these differential effects. Hyperplasia of gut-associated lymphoid tissues was also noted in dogs administered as little as 1 mg/kg/day (37) , providing further histological evidence for an effect of HCB on the immune system.
Mkiex
Mirex is a cyclodiene contact insecticide, although it has had several other applications. Its use in Canada has been banned since 1978. It is one of the most stable chemicals known, but it does slowly break down to photomirex (8-monohydromirex), a toxic chemical that contains one less chlorine atom than mirex.
Single doses of mirex are moderately acutely toxic in laboratory animals. The acute oral LD50 of mirex in rats is 600 to 700 mg/kg. Mirex causes several effects in laboratory animals, induding morphological changes in the liver (0.05 mg/kg/day), fetotoxicity (1-2 mg/kg/day), and carcinogenicity (5-10 mg/kg/day) (38) (41) . In related studies, impairment of macrophage phagocytosis, as well as suppression of antibody responses to both T-dependent and T-independent antigens, was also observed, albeit at similar high acute ip doses (42, 43) . The investigators suggested that the former changes contribute to increased susceptibility of C57B1/6 mice to challenge with MHV3 in vivo seen in earlier studies (44) . In spite of these effects, the biological significance of these observations in light of the comparatively low toxicity of dieldrin can be questioned.
In continued studies, impairment of T-cell-mediated graft-versus-host reactions was seen in recipient mice receiving allogeneic lymphoid cell suspensions from dieldrin-treated mice (45 (46) . As to the LD50 value above, the doses used in the above studies are relatively high. Furthermore, the LOEL could not be estimated from these studies. Dichlorodiphenyltrichloroethane Dichlorodiphenyltrichloroethane (DDT) was developed in the late 1930s and it was used extensively as a broad-spectrum contact organochlorine insecticide. Its use peaked in the early 1960s, with U.S production at 176 million pounds in 1963. In 1973, DDT was banned in the United States except for essential public health purposes. In the early 1970s, most uses of DDT were banned in Canada, but the last remaining product registration was not discontinued until 1989.
Although DDT is relatively stable, it undergoes a relatively complex series of biological degradative changes. The most important of these is dehydrochlorination to dichlorodiphenyldichloroethylene (DDE). DDE is more lipid soluble and, as a result, is much less toxic to mammals than DDT. Like the parent compound, DDE is retained in tissues for long periods of time.
The acute oral LD50 for DDT in rats is approximately 100 mg/kg. In contrast to the other priority pesticides found in the Great Lakes Basin, numerous studies have been conducted on the effect of DDT on the immune system of laboratory animals (39, (47) (48) (49) (50) . In general, the immune system is not a sensitive target organ for toxicity. Differences in species used, dose, duration, routes of exposure, and parameters evaluated make it difficult to estimate a LOEL for the immune system. However, the lowest in vivo immunosuppressive effects of DDT were based upon histopathological changes in lymphoid organs in rabbits fed the equivalent of 0.18 mg/kg DDT/day for up to 8 weeks (11) .
Acute DDT poisoning in humans is rare, considering its widespread use. A single oral dose of 10 mg/kg produces toxicity in humans. There is no evidence of any adverse long-term effects resulting from small daily doses of DDT and no conclusive evidence that DDT is immunosuppressive in humans inadvertently exposed through the food chain. Recent reports (51) have cited an association between DDT exposure and appearance of breast cancer, but the relationship of this observation to changes in tumor surveillance mechanisms has not been established.
Chlordane
Chlordane has had a wide variety of applications since its development as an insecticide in the mid-1940s. It was heavily used without restriction until the sole U.S. manufacturer voluntarily stopped production in 1988. Chlordane is absorbed and retained in lipid-containing tissues following any route of exposure; therefore, the potential exists for immunotoxicity. Laboratory animal studies have suggested that this compound adversely affects the immune system, especially in the fetus. In 1982, Spyker-Kranmer et al. (52) reported that the offspring of mice treated perinatally with chlordane exhibited suppressed cell-mediated immunity (CMI) compared to controls. In the absence of effects on adult animals (53), chlordane appears to exert immunotoxic effects in utero. Menna et al. (54) demonstrated that, compared to controls, chlordane-exposed offspring are capable of withstanding a higher challenge dose of influenza virus in the absence of effects on viral replication in vivo (55) . Diminution of viral specific delayed-type hypersensitivity responses in the absence of changes in T-cell blastogenesis at maternal chlordane dose levels of 4 mg/kg/day may have minimized infectious pathogenesis and contributed to increased survival (56) . In further studies, persistent suppression of adult bone marrow colony formation was noted in perinatally treated animals (57) with females exhibiting greater sensitivity (58) . Furthermore, recent studies suggest that 8 mg/kg maternal doses of chlordane differentially introduce defects in macrophage biochemical mechanisms associated with tumor cell killing in offspring (59) . In vitro studies suggest that chlordane impairs early activational events in antibody synthesis, albeit at relatively high concentrations of up to 10 fM (60) .
Unlike other organochlorine compounds, the above studies suggest that perinatal exposure to chlordane induces long lasting and subtle effects on immune function. The in vivo perinatal exposure model used in many of the above studies, however, achieves a total maternal chlordane dose that approaches 3 (65) . However, in a study of pesticide workers exposed to combinations of four widely used organophosphate and organochlorine pesticides (malathion, parathion, DDT, and hexachlorocyclohexane), 73% showed signs of toxicity, including altered levels of serum immunoglobulin levels (66) . Increases in serum IgG but decreases in serum IgM and complement C3 were reported in a study of 51 men exposed to chlorinated pesticides as compared to a 28-man control group. Immune complexes were suggested as a possible significant factor in occupational diseases (67) . In each of these studies, a direct association with a change in immune status was absent. Some in vitro studies complement these findings by showing that either paraoxon or malathion reduces both erythrocyte and granulocyte stem-cell colony formation and thus support the principle that pesticides affect stem cell growth (68) .
Although it is well documented that exposure to organophosphorus compounds alters human monocyte carboxylesterase activity (69) (70) (71) , the biological significance of this effect is still unclear. The concentrations of organophosphorus compounds causing 50% inhibition of monocyte esterase activity have been determined to be in the 1 to 10 pM range (72) . Although no measurements were taken, Newcombe and Esa (8) Although considerable information is known about the molecular mechanisms of esterase inhibition and functional immune impairment by organophosphorus compounds, there is no convincing evidence that humans occupationally exposed to these materials have higher incidences of infection or disease (69, 70) . Hermanowicz and Kossman (76) examined neutrophil function and prevalence of respiratory infections in workers occupationally exposed to organophosphate pesticides compared to controls. Inhibition of serum and red blood cell cholinesterase correlated with degree of exposure. In contrast to the studies described above, increased overall incidence of respiratory infection was observed in exposed workers compared to controls. In addition, the incidence of recurrent infection was positively correlated with length of exposure. Impairment of neutrophil chemotaxis was also observed; however, in workers exhibiting increased morbidity, neutrophil function was similar to those that were healthy. It was concluded that inhibition of host defense was not due to impairment of neutrophil function but may have resulted from other nonspecific effects on the lung.
Summary and Conclusions
In summary, it is clear that under carefully controlled laboratory conditions pesticides and related compounds associated with the Great Lakes basin are capable of modulating the immune system of experimental animals. However, in assessing potential risks to the immune system of Great Lakes residents from environmental exposure to these compounds, problems include determining the exposure variables related to a particular compound, identifying the appropriate immunologic end points for evaluation, and interpreting the data gathered as a result of these evaluations. Subtle heterogeneous, making it difficult to discern a subtle adverse effect without a large experimental cohort.
In conclusion, it is clear from the literature that levels of organochlorine or organophosphate pesticides required to modulate the immune system of experimental animals are considerably higher than levels in humans from estimated dietary exposure. Furthermore, around the Great Lakes, the levels of these pesticides entering the food chain are, for the most part, continuing to decrease. Therefore, the risk to the human immune system from environmental or dietary exposure to these xenobiotics is probably quite low.
